India is among signatories to UN declaration on antimicrobial resistance (AMR). Despite existing action plan, India reports cases of superbugs—pathogens resistant to multiple antibiotics.
ICMR & Hyderabad-based Indian Immunologicals come together to develop vaccine for vector-borne disease being seen as emerging threat. India reported nearly 600 Zika cases this year.
ICMR is working on guidelines on empirical use of antibiotics. Misuse of empirical antibiotics leads to antimicrobial resistance, a major public health challenge in India.
ICMR had in 2019 licensed technology for scaling up and commercialisation of its shigella vaccine to MSD-Wellcome Trust Hilleman Laboratories, but the deal fell through.
Nutrition think tank NAPi releases report based on study conducted over past 7 months, as part of which print, TV ads of 50 popular brands of packaged food and beverages were analysed.
Hyderabad-based vaccine maker says not including ICMR in original patent application for Covaxin was ‘inadvertent error’ & ‘confidential agreement between them was not accessible’.
New Delhi: In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established...
Doctors & experts are divided on the move's efficacy. Some believe this could help ensure responsible use, while others feel it could reduce access for those benefiting from it.
Study, which said nearly 30 percent of Covaxin recipients suffered from one or other side-effects, is 'misleading', says ICMR head. Journal & authors threatened with legal action.
The proportion of deaths due to such diseases increased to 61.8% in 2016 from 37.9% in 1990. Experts emphasise the need for diet plans tailored to Indian habits & lifestyle.
Indian judiciary has a corrosive imbalance between the bar and the bench. Those who supervise the district judiciary do so without the lived experience that is essential for meaningful reform.
With the US-India trade deal yet to get done, rupee depreciation may be helping to mitigate India’s loss of competitiveness. The other problem is extreme despondence among overseas equity investors.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS